Polymeric surfactant based etodolac chewable tablets: formulation and in vivo evaluation

scientific article published on 7 December 2010

Polymeric surfactant based etodolac chewable tablets: formulation and in vivo evaluation is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1045139338
P356DOI10.1208/S12249-010-9548-Z
P932PMC publication ID3011074
P698PubMed publication ID21136309
P5875ResearchGate publication ID49662767

P2093author name stringDoaa Ahmed El-Setouhy
Mohamed El-Nabarawi
Magdy M Ibrahim
Montasir A Fadlalla
P2860cites workDesign, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone.Q30966309
Production and characterization of Hesperetin nanosuspensions for dermal deliveryQ33402012
Fast-dissolve drug delivery systems.Q33885861
Improving drug solubility for oral delivery using solid dispersionsQ33935264
Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain statesQ34591536
Nanosizing: a formulation approach for poorly-water-soluble compoundsQ35069024
Effectiveness of etodolac (‘Lodine’) compared with naproxen in patients with acute goutQ39512505
Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.Q40017793
The concept of dissolution efficiencyQ40313091
Synthesis and cytotoxicity of water soluble quaternary salt derivatives of camptothecinQ40540572
Comparison of the effect of tromethamine and polyvinylpyrrolidone on dissolution properties and analgesic effect of nimesulide.Q41989862
Enhanced oral bioavailability of etodolac by self-emulsifying systems: in-vitro and in-vivo evaluationQ43058476
Dissolution rate enhancement by in situ micronization of poorly water-soluble drugsQ44275399
Development and characterization of naproxen-chitosan solid systems with improved drug dissolution propertiesQ44428858
Chemopreventative effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamstersQ45119225
Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutionsQ45524973
Enhancement of dissolution rate of piroxicam using liquisolid compactsQ46452274
Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environmentQ46627199
Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriersQ46794408
Biopharmaceutics classification system: the scientific basis for biowaiver extensionsQ74614652
Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine)Q80325417
Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugsQ82965679
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)1730-1737
P577publication date2010-12-07
P1433published inAAPS PharmSciTechQ15750612
P1476titlePolymeric surfactant based etodolac chewable tablets: formulation and in vivo evaluation
P478volume11

Reverse relations

cites work (P2860)
Q52726047Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: a preclinical study.
Q48030069Development of an Enantioselective and Biomarker-Informed Translational Population Pharmacokinetic/Pharmacodynamic Model for Etodolac

Search more.